A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease. [electronic resource]
Producer: 20160419Description: 662-71 p. digitalISSN:- 1755-5949
- 3,4-Dihydroxyphenylacetic Acid -- metabolism
- Animals
- Cell Survival -- drug effects
- Corpus Striatum -- drug effects
- DNA-Binding Proteins
- Disease Models, Animal
- Dopamine -- metabolism
- Dopamine and cAMP-Regulated Phosphoprotein 32 -- metabolism
- Dose-Response Relationship, Drug
- Female
- Homovanillic Acid -- metabolism
- Huntington Disease -- drug therapy
- Mice, Transgenic
- Motor Activity -- drug effects
- Nerve Tissue Proteins -- metabolism
- Neurons -- drug effects
- Neuroprotective Agents -- pharmacology
- Nuclear Proteins -- metabolism
- Serotonin Plasma Membrane Transport Proteins -- metabolism
- Tyrosine 3-Monooxygenase -- metabolism
- Vesicular Monoamine Transport Proteins -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.